Microgynon 30 clinical trials

(WHAT!) – RCT: Open-label randomized controlled trial for the effects of continuous daily use of ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the treatment of menstrually-related migraine and perimenopausal migraine

This study is looking at how two treatments, a common hormone pill (like Microgynon 30) and vitamin E, compare for women who get migraines linked to their period or during menopause. Researchers want to see if these treatments can reduce how often and how severely these migraines happen.